Find clinical trials for Acute Myeloid Leukemia (AML) in Orlando, FL
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Acute Myeloid Leukemia (AML) trials near Orlando, FL, USA:
The main objective of this study is to evaluate the efficacy of venetoclax in combination with azacitidine to improve Overall Survival (OS) in Acute...
Phase 3
Orlando, Florida, United States and 164 other locations
to venetoclax + azacitidine in adults recently diagnosed with AML who are unable to be treated with intensive chemotherapy.Participants will...
Phase 2
Orlando, Florida, United States and 56 other locations
\[GO\]) improves survival of children/adolescents/young adults with acute myeloid leukemia (AML) in 1st relapse w...
Phase 3
Orlando, Florida, United States and 78 other locations
which contains populations of CD8+ T cells targeting multiple leukemia associated antigen peptides in patients with Acute Myeloid...
Phase 1, Phase 2
Orlando, Florida, United States and 4 other locations
). Both parts will be conducted in participants with previously untreated CD123+ AML who are ineligible for intensive chemotherapy....
Phase 2
Orlando, Florida, United States and 35 other locations
This study is a first-in-human, Phase 1a/1b, multicenter, open-label study to determine the safety, tolerability, and pharmacokinetics of aplitabart...
Phase 1
Lake Mary, Florida, United States and 57 other locations
combination with chemotherapy in participants with newly diagnosed FMS-like tyrosine kinase 3 (FLT3)-internal tandem duplication (ITD) negative acute...
Phase 3
Kissimmee, Florida, United States and 252 other locations
with intensive chemotherapy in participants with newly diagnosed acute myeloid leukemia (AML) harboring alteratio...
Phase 1
Orlando, Florida, United States and 13 other locations
drug cusatuzumab added to venetoclax and azacitidine works to treat acute myeloid leukemia (AML) compared to vene...
Phase 2
Orlando, Florida, United States and 26 other locations
Trial of DFP-10917 vs Non-Intensive or Intensive Reinduction for AML Patients in 2nd/3rd/4th Salvage
Phase III, multicenter, randomized study with two arms (1:1 ratio) enrolling patients with AML relapsed/refractory after 2, 3, or 4 prior in...
Phase 3
Orlando, Florida, United States and 38 other locations
Clinical trials
Research sites
Resources
Legal